Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ABT.SW Stock Summary
In the News
ABT.SW Financial details
Company Rating
Strong Buy
Market Cap
175.63B
Income
5.8B
Revenue
41.51B
Book val./share
-
Cash/share
-
Dividend
1.96
Dividend %
1.76%
Employees
115K
Optionable
No
Shortable
Yes
Earnings
18 Jul 2023
P/E
33.44
Forward P/E
14.98
PEG
-37.25
P/S
4.68
P/B
5.29
P/C
-
P/FCF
24.88
Quick Ratio
1.23
Current Ratio
1.63
Debt / Equity
-
LT Debt / Equity
0.42
-
-
EPS (TTM)
3.65
EPS next Y
6.11
EPS next Q
-
EPS this Y
-0.75%
EPS next Y
67.36%
EPS next 5Y
67.36%
EPS last 5Y
24.16%
Revenue last 5Y
7.38%
Revenue Q/Q
-3.41%
EPS Q/Q
28.81%
-
-
-
-
SMA20
-
SMA50
-11.17%
SMA100
-9.41%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
16%
ROC
0.12%
Gross Margin
55%
Oper. Margin
17%
Profit Margin
14%
Payout
57%
Shs Outstand
1.74B
Shs Float
1.73B
-
-
-
-
Target Price
-
52W Range
98.0-121.0
52W High
-24.38%
52W Low
-6.63%
RSI
0.3
Rel Volume
-
Avg Volume
-
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
-9.41%
Perf Half Y
-9.41%
-
-
-
-
Beta
0.662913
-
-
Volatility
0%, 0%
Prev Close
0%
Price
91.5
Change
0%
ABT.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 17.42 | 18.1 | 19.54 | 24.42 | 25.04 | |
Net income per share | 1.35 | 2.09 | 2.54 | 4.01 | 3.98 | |
Operating cash flow per share | 3.59 | 3.48 | 4.46 | 5.97 | 5.5 | |
Free cash flow per share | 2.79 | 2.55 | 3.23 | 4.9 | 4.48 | |
Cash per share | 2.33 | 2.35 | 4.04 | 5.81 | 5.83 | |
Book value per share | 17.39 | 17.64 | 18.51 | 20.29 | 21.04 | |
Tangible book value per share | -6.54 | -5.06 | -3.12 | 0.03 | 2.09 | |
Share holders equity per share | 17.39 | 17.64 | 18.51 | 20.29 | 21.04 | |
Interest debt per share | 11.62 | 11.05 | 11.38 | 11.05 | 10.38 | |
Market cap | 121.36B | 157.18B | 205.33B | 227.82B | 190.49B | |
Enterprise value | 137.08B | 172.21B | 218.14B | 237.03B | 198.32B | |
P/E ratio | 51.25 | 42.63 | 45.68 | 32.22 | 27.48 | |
Price to sales ratio | 3.97 | 4.93 | 5.93 | 5.29 | 4.36 | |
POCF ratio | 19.26 | 25.62 | 25.99 | 21.63 | 19.88 | |
PFCF ratio | 24.74 | 34.94 | 35.87 | 26.34 | 24.41 | |
P/B Ratio | 3.98 | 5.06 | 6.26 | 6.36 | 5.19 | |
PTB ratio | 3.98 | 5.06 | 6.26 | 6.36 | 5.19 | |
EV to sales | 4.48 | 5.4 | 6.3 | 5.5 | 4.54 | |
Enterprise value over EBITDA | 19.55 | 25.86 | 28.73 | 22.05 | 18.54 | |
EV to operating cash flow | 21.76 | 28.07 | 27.61 | 22.5 | 20.7 | |
EV to free cash flow | 27.94 | 38.29 | 38.11 | 27.41 | 25.41 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
Free cash flow yield | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | |
Debt to equity | 1.19 | 1.18 | 1.21 | 1.09 | 1.02 | |
Debt to assets | 0.54 | 0.54 | 0.55 | 0.52 | 0.5 | |
Net debt to EBITDA | 2.24 | 2.26 | 1.69 | 0.86 | 0.73 | |
Current ratio | 1.62 | 1.44 | 1.72 | 1.85 | 1.63 | |
Interest coverage | 4.42 | 7.87 | 10.71 | 17.19 | 22.3 | |
Income quality | 2.66 | 1.66 | 1.76 | 1.49 | 1.38 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.83 | 0.62 | 0.57 | 0.45 | 0.48 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.08 | 0.07 | 0.06 | 0.07 | |
Intangibles to total assets | 0.63 | 0.59 | 0.53 | 0.48 | 0.45 | |
Capex to operating cash flow | -0.22 | -0.27 | -0.28 | -0.18 | -0.19 | |
Capex to revenue | -0.05 | -0.05 | -0.06 | -0.04 | -0.04 | |
Capex to depreciation | -0.43 | -0.54 | -0.65 | -0.53 | -0.54 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
Graham number | 22.97 | 28.81 | 32.51 | 42.78 | 43.39 | |
ROIC | 0.05 | 0.07 | 0.09 | 0.14 | 0.14 | |
Return on tangible assets | 0.09 | 0.13 | 0.13 | 0.18 | 0.17 | |
Graham Net | -15.14 | -14.88 | -14.16 | -12.18 | -10.1 | |
Working capital | 5.62B | 4.8B | 8.53B | 11.13B | 9.74B | |
Tangible asset value | -11.47B | -8.92B | -5.53B | 54M | 3.65B | |
Net current asset value | -21.82B | -20.92B | -19.1B | -14.93B | -12.31B | |
Invested capital | 0.64 | 0.61 | 0.6 | 0.53 | 0.48 | |
Average receivables | 5.22B | 5.3B | 5.92B | 6.45B | 7.68B | |
Average payables | 2.69B | 3.11B | 3.6B | 4.18B | 4.51B | |
Average inventory | 3.7B | 4.06B | 4.66B | 5.08B | 5.67B | |
Days sales outstanding | 61.86 | 62.07 | 67.65 | 54.97 | 74.26 | |
Days payables outstanding | 85.46 | 89.71 | 96 | 86.8 | 87.85 | |
Days of inventory on hand | 109.05 | 119.06 | 121.93 | 101.54 | 117.71 | |
Receivables turnover | 5.9 | 5.88 | 5.4 | 6.64 | 4.92 | |
Payables turnover | 4.27 | 4.07 | 3.8 | 4.21 | 4.15 | |
Inventory turnover | 3.35 | 3.07 | 2.99 | 3.59 | 3.1 | |
ROE | 0.08 | 0.12 | 0.14 | 0.2 | 0.19 | |
Capex per share | -0.79 | -0.93 | -1.23 | -1.07 | -1.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 6.79 | 6.43 | 8.34 | 5.81 | 5.61 | |
Net income per share | 1.4 | 1.15 | 1.15 | 0.59 | 0.76 | |
Operating cash flow per share | 1.18 | 1.38 | 2.23 | 1.34 | 0 | |
Free cash flow per share | 1 | 1.16 | 1.85 | 0.99 | 0 | |
Cash per share | 4.66 | 5.3 | 7.94 | 5.85 | 0 | |
Book value per share | 20.22 | 20.84 | 28.59 | 21.11 | 0 | |
Tangible book value per share | 0.13 | 1.36 | 2.2 | 2.1 | 0 | |
Share holders equity per share | 20.22 | 20.84 | 28.59 | 21.11 | 0 | |
Interest debt per share | 9.83 | 9.63 | 13.22 | 10.23 | 0 | |
Market cap | 208.07B | 191.59B | 135.67B | 189.86B | 180.76B | |
Enterprise value | 217.49B | 199.42B | 142.49B | 197.69B | 0 | |
P/E ratio | 21.26 | 23.74 | 23.64 | 45.95 | 34.29 | |
Price to sales ratio | 17.49 | 17.02 | 13.03 | 18.81 | 18.55 | |
POCF ratio | 100.76 | 79.5 | 48.8 | 81.62 | 0 | |
PFCF ratio | 119.31 | 94.33 | 58.66 | 110.64 | 0 | |
P/B Ratio | 5.88 | 5.25 | 3.8 | 5.18 | 0 | |
PTB ratio | 5.88 | 5.25 | 3.8 | 5.18 | 0 | |
EV to sales | 18.28 | 17.71 | 13.69 | 19.59 | 0 | |
Enterprise value over EBITDA | 62.1 | 67.26 | 60.35 | 105.83 | 0 | |
EV to operating cash flow | 105.32 | 82.75 | 51.26 | 84.99 | 0 | |
EV to free cash flow | 124.71 | 98.19 | 61.6 | 115.2 | 0 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.01 | 0 | |
Debt to equity | 1.08 | 1.03 | 1.03 | 1.02 | 0 | |
Debt to assets | 0.52 | 0.51 | 0.51 | 0.5 | 0 | |
Net debt to EBITDA | 2.69 | 2.64 | 2.89 | 4.19 | 0 | |
Current ratio | 1.85 | 2.01 | 1.86 | 1.63 | 0 | |
Interest coverage | 24.89 | 22.42 | 20.58 | 19.76 | 29.02 | |
Income quality | 0.84 | 1.19 | 1.94 | 2.25 | 0 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0.34 | 0.41 | 0.58 | 0.8 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.06 | 0.06 | 0.08 | 0.07 | 0.07 | |
Intangibles to total assets | 0.48 | 0.46 | 0.46 | 0.45 | 0 | |
Capex to operating cash flow | -0.16 | -0.16 | -0.17 | -0.26 | 0 | |
Capex to revenue | -0.03 | -0.03 | -0.04 | -0.06 | 0 | |
Capex to depreciation | -0.39 | -0.46 | -0.57 | -0.76 | 0 | |
Stock based compensation to revenue | 0.03 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 25.21 | 23.24 | 27.2 | 16.8 | 0 | |
ROIC | 0.05 | 0.04 | 0.03 | 0.02 | 0 | |
Return on tangible assets | 0.06 | 0.05 | 0.04 | 0.03 | 0 | |
Graham Net | -12.56 | -11.33 | -15.5 | -10.14 | 0 | |
Working capital | 10.78B | 12.56B | 11.48B | 9.74B | 0 | |
Tangible asset value | 225M | 2.38B | 2.75B | 3.65B | 0 | |
Net current asset value | -14.95B | -12.53B | -12.07B | -12.31B | 0 | |
Invested capital | 0.48 | 0.46 | 0.46 | 0.48 | 0 | |
Average receivables | 6.83B | 7.19B | 6.8B | 7.64B | 0 | |
Average payables | 4.58B | 4.63B | 4.31B | 4.37B | 0 | |
Average inventory | 5.42B | 5.8B | 5.82B | 5.95B | 0 | |
Days sales outstanding | 54.32 | 57.56 | 55.4 | 79.21 | 0 | |
Days payables outstanding | 85.85 | 81.97 | 80.36 | 90.27 | 0 | |
Days of inventory on hand | 102.71 | 107.62 | 111.48 | 120.96 | 0 | |
Receivables turnover | 1.66 | 1.56 | 1.62 | 1.14 | 0 | |
Payables turnover | 1.05 | 1.1 | 1.12 | 1 | 0 | |
Inventory turnover | 0.88 | 0.84 | 0.81 | 0.74 | 0 | |
ROE | 0.07 | 0.06 | 0.04 | 0.03 | 0 | |
Capex per share | -0.18 | -0.22 | -0.37 | -0.35 | 0 |
ABT.SW Frequently Asked Questions
What is Abbott Laboratories stock symbol ?
Abbott Laboratories is a US stock , located in North chicago of Il and trading under the symbol ABT.SW
What is Abbott Laboratories stock quote today ?
Abbott Laboratories stock price is $91.5 today.
Is Abbott Laboratories stock public?
Yes, Abbott Laboratories is a publicly traded company.